1. Soluble complement receptor 1 preserves endothelial barrier function and microcirculation in postischemic pancreatitis in the rat
- Author
-
von Dobschuetz, E., Bleiziffer, O., Pahernik, S., Dellian, M., Hoffmann, T., and Messmer K.
- Subjects
Ischemia -- Research ,Biological sciences - Abstract
Components of the activated complement cascade are considered to play a pivotal role in ischemia-reperfusion-induced organ injury. With the use of intravital epifluorescence microscopy, we investigated the effect of complement inhibition by the recombinant soluble complement receptor 1 (sCR1; TP10) on the effect of macromolecular microvascular permeability, functional capillary perfusion, and leukocyte endothelium interaction in postischemic pancreatitis. Anaesthetized Sprague-Dawley rats were subjected to 60 min of normothermic pancreatic ischemia induced by micro-clipping of the blood-supplying arteries of the organ. Rats who received sCR1 (15 mg/kg body wt iv; n = 7) during reperfusion showed a significant reduction of permeability (1.77 [+ or -] 1.34 x [10.sup.-8] cm/s; n = 7) of tetramethylrhodamine isothiocyanate-labeled albumin injected 90 min after the onset of reperfusion compared with vehicle-treated animals (6.95 [+ or -] 1.56 x [10.sup.-8] cm/s; n = 7). At 120 min after the onset of reperfusion, the length of red blood cell-perfused capillaries (functional capillary density) was significantly improved (from 279 [+ or -] 15.7 to 330 [+ or -] 3.7 [cm.sup.-1]; n = 7) and the number of leukocytes adherent to postcapillary venules was significantly reduced (from 314 [+ or -] 87 to 163 [+ or -] 71 [mm.sup.-2]; n = 7) by sCR1 compared with vehicle treatment. Complement inhibition by sCR1 effectively ameliorates pancreatic ischemia-reperfusion-induced microcirculatory disturbances and might be considered for treatment of postischemic pancreatitis. permeability; ischemia; reperfusion; acute pancreatitis; transplantation
- Published
- 2004